Middle East and Africa Medicinal Chemistry for Drug Discovery Market, By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Design (Fragment-Based Variation, Structure-Based Drug Design, Diversity Oriented Synthesis, Chemogenomics, Natural Products and Others), Drug Type (Small Molecules and Biologics), Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Cardiovascular Diseases, Digestive System Diseases and Others), End User (Contract Research Organization, Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes and Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights: Middle East and Africa Medicinal Chemistry for Drug Discovery Market
Middle East and Africa medicinal chemistry for drug discovery market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.7% in the forecast period of 2022 to 2029 and is expected to reach USD 94.19 million by 2029. The rising prevalence of diseases such as Alzheimer’s, AIDS and other drug-resistant infectious diseases and increasing focus for the development of novel drugs for evolving diseases are the major drivers which propelled the demand of the market in the forecast period.
Medicinal chemistry is the interdisciplinary field of science that involves a team of scientists (including synthetic organic chemists, analytical chemists, biologists, toxicologists, pharmacologists, microbiologists, and biopharmacists) working together for drug discovery, design, development and synthesis of new pharmaceuticals. Moreover, the contribution of medicinal chemistry is not confined just to the discovery stage. It carries its purpose along the entire spectrum of clinical development. Each and every stage of clinical development involves surplus amounts of formulated drugs for studying potential benefits in human trials. With time the chemical methods adopted for the discovery of the molecules have also undergone changes leading to the development of technologies such as combinatorial chemistry (combichem), microwave assisted organic synthesis (MAOS) and high-throughput (HTS) biological screening.
Medicinal chemistry for drug discovery comprises features such increasing need for safe and effective drugs will impact in launching new product by the manufactures into the market which enhance its demand as well as increase in research and development investment for discovery and development of novel drug molecules leads to the market growth. Currently various research studies are taking place which is expected to provide various other opportunities in the medicinal chemistry for drug discovery market. However, technical risks in drug discovery and lack of trained skilled professionals expected to restraint the market growth in the forecast period.
The medicinal chemistry for drug discovery market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Medicinal Chemistry for Drug Discovery Market Scope and Market Size
Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user.The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of process, the global medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the global medicinal chemistry for drug discovery market as it is the first process from where the drug discovery begins and where the biological targets are selected in an area of unmet medical needs. Before target validation target efficacy, safet, potential genetic variation are investigated under the target selection process.
- On the basis of design, the global medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug deisgn, diversity oriented synthesis, chemogenomics, natural products and others. In 2022, the fragment based variation segment is expected to dominate the global medicinal chemistry for drug discovery market due to the fact that many potent compounds/ inhibitors of diverese targets have been developed using this method. Moreover, it is a powerful method to develop small-molecule compounds starting from fragments binding weakly to targets. Another advantage of fragment based medicinal chemistry meethods is that it offers saving experimental costs, offers diverse hits and plays important role in target-based drug discovery.
- On the basis of drug type, the global medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market due to the fact that as per the market study most of the drug discovery orgsnizations are highly focused on small molecules discovery and less focused on biologics including proteins, peptides among others.
- On the basis of therapeutic area, the global medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalance of cancer and increasing number of clinical trials and research & development activities for development of novel therapeutics.
- On the basis of end user, the global medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the global medicinal chemistry for drug discovery market as most of the market is occupied by contract research organization it is expected to dominate the market. Moroever, major market players signs collaborative agreement with contract research organizations for ongoing clinical trials in order to attain early drug development and approval.
Medicinal Chemistry for Drug Discovery Market Country Level Analysis
The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.
The countries covered in the medicinal chemistry for drug discovery market report are the Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.
South Africa is expected to dominate the market due to the rising funding by several private-public foundations for research projects across South African universities and research institutions.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growth in Biologics and Initiatives for Research on Rare and Orphan Drugs are boosting the Market Growth of Medicinal Chemistry for Drug Discovery
Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis
Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.
Some of the major players operating in the medicinal chemistry for drug discovery market are Eurofins Scientific, Covance Inc. (now part of the LabCorp Group), WuXi Apptec, Charles River, Thermo Fisher Scientific, Inc., Evotec SE, Piramal Pharma Solutions, Pfizer, Inc., Certara, USA, Sygnature Discovery Limited, Malvern Panalytical Ltd (Parent Company Spectris PLC), Jubilant Biosys Ltd. (A Jubilant Pharmova Limited Company), Taros Chemicals GmbH & Co. KG, Genscript Biotech Corporation, Nereid Therapeutics Inc., BioBlocks, Inc., Charnwood Molecular LTD, Domainex, Aurigene Pharmaceutical Services Ltd. (a subsidiary of Dr. Reddy’s Laboratories Ltd.), Selvita, Nanosyn, and Drug Discovery Alliances Inc. among others.
Various market players provide with the latest technologies of medicinal chemistry for drug discovery which are also accelerating the medicinal chemistry for drug discovery market.
For instance,
- In November 2021, Jubilant Biosys Limited expanded its facilities in order to support the drug discovery chemistry services and in-vitro ADME services. Moreover, the company is providing services for Turning Point Therapeutics Inc. for small molecule oncology research programs. Through this expansion the company has leveraged its offering which allowed it to penetrate its root in global medicinal chemistry for drug discovery market.
- In February 2021, Eurofins acquired Beacon Discovery for its years of experience in drug discovery and development and innovative approach. Beacon Discovery is also well known for its profound expertise in GPCR (G-Protein Coupled Receptor) research. Through this acquisition the company has strengthen its presence in global medicinal chemistry for drug discovery market.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the medicinal chemistry for drug discovery which also provides the benefit for organization to improve their offering for bronchiectasis.
SKU-